Ligand validation:6GXV

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 6GXV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GXV_GLC_A_507	50%	39%	0.135	0.883	0.6	1.73	-	5	0	0	100%	1
6GXV_GLC_B_512	37%	22%	0.174	0.872	1.13	2.1	1	6	1	0	100%	1
6GXV_GLC_A_511	35%	43%	0.156	0.845	1.17	1.03	-	-	0	0	100%	0.7
6GXV_GLC_B_504	30%	33%	0.179	0.84	1.21	1.45	1	3	0	0	100%	0.7
6GYA_GLC_B_510	15%	33%	0.28	0.846	1.32	1.33	1	3	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1
2JJB_GLC_D_1548	98%	55%	0.07	0.989	0.73	1	-	2	0	0	100%	1
6FWL_GLC_A_403	97%	57%	0.05	0.981	0.53	1.11	-	1	0	0	92%	0.9167
4KWU_GLC_A_1114	97%	69%	0.067	0.98	0.56	0.65	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.